DEACYLATED ALFUZOSIN
UNII X166NKW50I

Substance Identification & Data

This profile provides standardized clinical and technical data for Deacylated Alfuzosin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X166NKW50I.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 76362-29-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

X166NKW50I

CAS Registry Number

76362-29-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DEACYLATED ALFUZOSIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C14H21N5O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

HVTJQTPDNHTWGI-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

13544733

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1c(nc2c(c1N)cc(c(OC)c2)OC)N(CCCN)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Deacylated Alfuzosin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.